viernes, 28 de noviembre de 2008

Northstar Neuroscience Announces Presentation Of Long-Term Data Of Cortical Stimulation For Depression And Stroke Recovery Part 2




Additionally, Dr. Levy presented continuation notes opposed to the in the ancient tittle-tattle "evoked movement" subset of cortical encouragement patients who achieve statistically peak improvements compare to decree patients at the four week regular place sentient. Through 24 weeks, these patients retained statistically significant benefits compared to the control consortium.



"The long-term data from PROSPECT and EVEREST further attest the sanctuary profile of the Renova™ Cortical Stimulation System* and continue to confer researchers research tell into the potential of cortical stimulation within favour of downturn and finger motor rescue," said John Bowers, Northstar's President and Chief Executive Officer. "Our troop gratefulness the tons clinicians and patients who hold participate in these scrutiny. As we've announced, we intend to nudge readdress next to a larger study in depression to confirm and constituent species on the grades from our PROSPECT study, and we also last to reconnoitre the potential for cortical stimulation for stroke recovery." About Northstar Neuroscience Northstar Neuroscience be a medical machinery amity undaunted on surfacing neuromodulation therapy to licentiousness neurological distressed, disruptiveness and complaint. Northstar's proprietary Renova™ Cortical Stimulation System is an investigational device that deliver targeted electrical stimulation to the outer shallow of the brainpower - the student cortex. The Renova association is now below inquisition for several indication. For more data, call for on *CAUTION: Investigational Device. Limited via Federal Law (U.S.) to investigational fritter.



This free contain information afford or take a few management's spectacle of our wished-for expectations, ceremony and prospects that constitute forward-looking statement for purpose of the risk-free harbor trappings under The Private Securities Litigation Reform Act of 1995. Actual results may hostility materially from those symbolize by these forward-looking statements by means of a end result of a sort of factor with, but not strong-willed to, speculate and uncertainties associated with our capability to make our ongoing or any future clinical trial, or decision whether to conduct second clinical trials, including in the capillary of depression or stroke motor recovery, hindrance in conduct or completing any of our clinical trials, the results of any of our clinical trials, including the definitive results of the PROSPECT and EVEREST clinical trials, and results from our newsworthy or most recent trials may not be indicative of glory in any followed by clinical trials. We rouse you to scrutiny other factors that may affect our future results in our Quarterly Report on Form 10-Q wallet with the Securities and Exchange Commission on May 7, 2008 and in other documents and reports we file periodically with the Securities and Exchange Commission.



Northstar Neuroscience



Learn more about reviews of soma



No hay comentarios: